L Karen Tubridy

Affiliations

  • Svp, Chief Development Officer at Akebia Therapeutics Inc. (AKBA), 2020-03-03
  • Chief Development Officer at Eleven Biotherapeutics Inc. (EBIO), 2016-07-12
Insider Trading: Sales See All
Symbol Price Amount Total Value Remaining Holdings Date Form 4
AKBA $8.70 3,454 $30,049.80 84,679 2020-02-28 Filing
EBIO $2.08 4,372 $9,093.76 32,753 2016-06-27 Filing
EBIO $2.85 4,427 $12,616.95 32,973 2015-12-28 Filing